Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today reported its fourth quarter and full year 2025 operating and financial results and reviewed recent business highlights. “Over the past year ...

Physical activity programmes such as the NSC can help mitigate rising obesity and T2DM prevalence when implemented at the population level, as seen in Singapore. However, their success depends on ...

When combined with clinical markers, smartwatch data was able to help detect insulin resistance with nearly 90 percent ...

Giving an inpatient oral glucose tolerance test before delivery discharge for women with gestational diabetes tripled the ...

A major study by smart ring and CGM maker Ultrahuman highlights patterns between when you go to sleep and elevated blood ...